1,528 results on '"Menopause -- Care and treatment"'
Search Results
2. Bayer to unveil new data from its phase III OASIS 3 long-term study of elinzanetant to treat vasomotor symptoms associated with menopause
3. Researchers at Lund University Publish New Study Findings on Antineoplastics (Hormone receptor mRNA and protein levels as predictors of premenopausal tamoxifen benefit)
4. Bayer submits NDA to US FDA for elinzanetant to treat moderate to severe VMS associated with menopause
5. New Findings from University of Chicago Describe Advances in Biomarkers (Exosome Therapy: A Novel Approach for Enhancing Estrogen Levels in Perimenopause)
6. Some companies offer health benefits for employees managing menopause
7. Rethink on talking therapies for menopause
8. Liaoning Cancer Hospital and Institute Researcher Reports Recent Findings in Breast Cancer (Effect and acceptability of jasmine compound essential oil for premenopausal breast cancer survivors suffering from genitourinary syndrome of menopause: ...)
9. Data from Affiliated Hospital of Nanjing University of Chinese Medicine Advance Knowledge in Hot Flashes (Acupuncture with benefiting the kidney and consolidating the essence in the improving hot flashes after endocrine therapy for breast ...)
10. Nick Timothy ask the Secretary of State for Health and Social Care, what assessment he has made of the adequacy of access to hormone replacement therapies for women experiencing the menopause
11. Health officials backtrack on 'talking therapy' for menopause symptoms; Strengthened NHS guidance stresses that HRT should be the 'first-line treatment' for hot flushes, insomnia and low mood
12. DISCUSSION AID TO SUPPORT CLINICAL CONVERSATIONS ABOUT HRT PUBLISHED ALONGSIDE UPDATED GUIDANCE
13. Woman began menopause at 32 as a result of breast cancer treatment
14. Experts stress the need for hormone therapy during the menopause
15. The health effects of hormone therapy for menopause
16. Astellas begins patient dosing in STARLIGHT 2 phase 3 studies of fezolinetant for VMS associated with menopause in Japan
17. Study Data from Universidad de Los Andes Update Knowledge of Menopause (Hormone Therapy for Sexual Function In Perimenopausal and Postmenopausal Women)
18. Recent Studies from Universidade Federal de Sao Paulo (UNIFESP) Add New Data to Menopause (Fractional CO2 Laser, Radiofrequency and Topical Estrogen for Treating Genitourinary Syndrome of Menopause: A Pilot Study Evaluating the Vulvar Vestibule)
19. Menopause: getting it right for your patients
20. Non-Surgical Treatment of Heavy Menstrual Bleeding From Fibroids: A New Paradigm
21. Research from University of Illinois Has Provided New Data on Hormones (Cooling the flames: Navigating menopausal vasomotor symptoms with nonhormone medications)
22. Data from Phase III study OASIS 3 support efficacy and long-term safety of investigational compound elinzanetant in the treatment of moderate to severe vasomotor symptoms associated with menopause
23. Bayer to unveil new data from its Phase III OASIS 3 long-term study of elinzanetant in the treatment of vasomotor symptoms associated with menopause
24. Bayer to Unveil New Data From Its Phase III OASIS 3 Long-Term Study of Elinzanetant in the Treatment of Vasomotor Symptoms Associated With Menopause
25. New treatment from Bayer may help reduce menopause symptoms
26. New Inflammation Detection Tools, Treatment for Menopause
27. The Checkup With Dr. Wen: Who should -- and shouldn't -- use hormone therapy for menopause?
28. How one misinterpreted study tarnished hormone therapy for menopause
29. Hormone Replacement Therapy May Be Less Risky Than You Think: Timing is the key to safe and effective use of hormone therapy for menopause symptoms
30. New Menopause Study Findings Reported from Astellas Pharma Inc. (Systematic review and network meta-analysis comparing the efficacy of fezolinetant with hormone and nonhormone therapies for treatment of vasomotor symptoms due to menopause)
31. European Commission approves Astellas' veoza for treatment of vasomotor symptoms associated with menopause
32. Noema Pharma Announces First Patient Dosed in Phase 2a Study of NOE-115, a First-In-Class Investigational Therapy for the Treatment of Vasomotor Symptoms and Additional Symptoms Associated with Menopause
33. Bayer to unveil late-breaking data from Phase III OASIS 1 and 2 for elinzanetant in the treatment of vasomotor symptoms associated with menopause
34. Shoppers rush to buy 'game-changing' menopause patches which help with hot flushes, sleep, and mood swings; Those going through menopause suffer from a range of symptoms
35. Women say these menopause patches 'stop night sweats and eliminate hot flushes'; Those going through menopause can experience a variety of symptoms and menopause patches could help with them
36. Senate committee approves bill obliging SUS to treat menopausal and climacteric women
37. Therapy and meditation can ease menopause symptoms
38. Study Findings on Menopause Published by a Researcher at Massachusetts General Hospital (The complexity of genitourinary syndrome of menopause: number, severity, and frequency of vulvovaginal discomfort symptoms in women enrolled in a ...)
39. Phase 3b Trial of Fezolinetant Shows Positive Topline Results for Treatment of VMS Due to Menopause
40. HT for women who have had BSO before the age of natural menopause: Discerning the nuances
41. Evaluating symptomatic patients for appropriate hormone therapy
42. Astellas Pharma announces positive results from phase 3b trial of fezolinetant to treat VMS due to menopause
43. Reports Outline Experimental Diabetes Mellitus Research from Almazov National Medical Research Centre (Modern glucose-lowering treatment effect on bone remodeling in experimental diabetes mellitus and surgical menopause)
44. Sex after menopause doesn't need to hurt
45. Testosterone treatment gives life-altering relief to women going through menopause
46. MENOPAUSE: PCPs face increasing patient demand for knowledgeable care
47. Astellas Initiates Phase 3 Clinical Studies of Fezolinetant for VMS Associated with Menopause in Japan
48. DONESTA(R) safety study for menopause completes treatment phase and advances to data management & reporting phase
49. Knight Therapeutics Announces Launch of Bijuva(R) in Canada
50. Astellas to Air New VEOZAH (fezolinetant) TV Spot During the Super Bowl
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.